Centro de Investigación Médica Aguascalientes (CIMA),

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Migraine2 trials
• Pancreatic cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• NovoCure Ltd.1 trial

Running trials

• Active, not recruiting

  A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

  NCT04616326· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

  NCT03432286· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

  NCT03377491· Phase 3· NovoCure Ltd.· Source